Craneware (LON:CRW)‘s stock had its “buy” rating restated by investment analysts at Peel Hunt in a research note issued on Wednesday. They currently have a GBX 1,800 ($24.07) price objective on the stock. Peel Hunt’s price target points to a potential upside of 18.42% from the company’s previous close.
Separately, N+1 Singer reiterated a “hold” rating on shares of Craneware in a research note on Tuesday, September 5th.
Craneware (LON CRW) opened at GBX 1,548 ($20.70) on Wednesday. The company has a market cap of $433.65 and a P/E ratio of 4,300.00. Craneware has a 1 year low of GBX 1,165 ($15.58) and a 1 year high of GBX 1,885 ($25.20).
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
Receive News & Ratings for Craneware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Craneware and related companies with MarketBeat.com's FREE daily email newsletter.